Qiming Venture Partners led a Series A financing round for SANY Hydrogen Energy to enhance R&D and support the large-scale adoption of green hydrogen technologies.
Target Information
SANY Hydrogen Energy is a pioneering company focused on the research and development of green hydrogen technologies. Recently, they completed a Series A financing round of several hundred million RMB, which was led by Qiming Venture Partners. The capital raised will be utilized to enhance R&D efforts, upgrade manufacturing processes, and facilitate the large-scale adoption of green hydrogen solutions.
In parallel, other investments made by Qiming Venture Partners underscore their commitment to advancing innovative healthcare solutions, including financing provided to Zenitar for drug candidates entering Phase 3 trials and to Minghui Pharmaceutical for developing advanced therapeutic strategies in immuno-oncology.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in China
China's hydrogen energy sector has been gaining traction as part of the nation's broader strategy to transition toward cleaner energy solutions. The Chinese government has heavily invested in research and infra
Similar Deals
Qiming Venture Partners
invested in
SANY Hydrogen Energy
in 2025
in a Series A deal
Disclosed details
Transaction Size: $131M